MicroRNA-127-3p Inhibits In Vitro Osteogenesis and Dampens Trauma-Induced Heterotopic Ossification In Vivo

Victor Gustavo Balera Brito1,2, Austin Bell-Hensley3, Hongjun Zheng1

  • 1Department of Orthopaedic Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.

Insights

Overexpressing miR-127-3p inhibits bone formation and reduces ectopic bone growth. This microRNA

Area of Science:

  • Molecular Biology
  • Skeletal Biology
  • RNA Biology

Background:

  • MicroRNAs regulate cellular pathways and are crucial for skeletal development.
  • Elevated miR-127-3p levels are observed in osteoporotic patients and ovariectomized mice.
  • Previous studies suggest a role for miR-127-3p in bone formation regulation.

Purpose of the Study:

  • To investigate the function of miR-127-3p in osteogenic differentiation of human bone marrow-derived mesenchymal stromal cells (hBMSCs).
  • To assess the therapeutic potential of miR-127-3p in treating heterotopic ossification.

Main Methods:

  • Overexpression and inhibition of miR-127-3p in hBMSCs.
  • Bulk RNA-sequencing to identify affected cellular pathways.
  • In vivo studies using a mouse model of heterotopic ossification with local delivery of miR-127-3p mimics via nanoparticle technology.

Main Results:

  • miR-127-3p mimic overexpression robustly inhibited in vitro osteogenesis and cell proliferation.
  • RNA-sequencing revealed suppression of proliferation-related pathways.
  • Local delivery of miR-127-3p mimics significantly reduced ectopic bone formation in a mouse model.

Conclusions:

  • miR-127-3p acts as a negative regulator of osteogenic differentiation.
  • Overexpression of miR-127-3p suppresses bone formation and may be a therapeutic strategy for heterotopic ossification.